The American Geriatric Society (AGS) recommends against the use of tertiary TCAs (e.g. amitriptyline) for the treatment of pain in older patients (age ≥75 years) because of safety risks including cardiovascular effects, orthostatic hypotension, and cognitive impairment [32].